DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Vale CL, Burdett S, Rydzewska LHM. et al
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data.
The Lancet Oncology 2016;
17: 243-256 . doi:10.1016/S1470-2045(15)00489-1
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.